Abstract
The cleavage stage embryo (days 1–3) stands out due to the high level of chromosomal anomalies, especially mosaicism that arises prior to global embryonic genome activation. Molecular cytogenetic studies show that an average of 60% of in vitro derived embryos have at least one aneuploid cell by the time they are 3 days old. However, comprehensive studies of the chromosome content of individual cells have revealed that 25% of these embryos have no aneuploid cells, a fact that sits well with the knowledge that at most 1 in 5 have the capacity to implant. The evidence is that extensive mosaicism, affecting several chromosomes, interferes with development to a greater extent than does uniform aneuploidy. Follow-up studies on embryos after pre-implantation genetic aneuploidy screening indicate that the frequency of meiotic errors varies according to the referral reason, with the highest frequency being recorded for the recurrent miscarriage category and the lowest in the repeated implantation failure group where younger women have a good response to ovarian stimulation. The exceptionally high incidence of pre- and post-zygotic chromosomal anomalies seen in early human embryos is thus the product of several mechanisms. Firstly, the error-prone cell cycle during the embryonic cleavage stage and secondly, parental susceptibility to meiotic and mitotic chromosomal instability together with their general genetic background.
References
1.
Avo Santos M, Teklenburg G, Macklon NS, Van Opstal D, Schuring-Blom GH, et al: The fate of the mosaic embryo: chromosomal constitution and development of day 4, 5 and 8 human embryos. Hum Reprod 25:1916–1926 (2010).
2.
Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, et al: Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo. Hum Reprod 22:980–988 (2007).
3.
Bean C, Hunt P, Millie A, Hassold T: Analysis of a malsegregating mouse Y chromosome: evidence that the earliest cleavage divisions of the mammalian embryo are non-disjunction-prone. Hum Mol Genet 10:963–972 (2001).
4.
Bielanska M, Tan SL, Ao A: Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome. Hum Reprod 17:413–419 (2002).
5.
Braude P., Bolton V, Moore S. Human gene expression first occurs between the four- and eight-cell stages of preimplantation development. Nature 333:459–461 (1988).
6.
Chatzimeletiou K, Morrison EE, Prapas N, Prapas Y, Handyside AH: Spindle abnormalities in normally developing and arrested human preimplantation embryos in vitro identified by confocal laser scanning microscopy. Hum Reprod 20:672–682 (2005).
7.
Coonen E, Harper JC, Ramaekers FC, Delhanty JD, Hopman AH, et al: Presence of chromosomal mosaicism in abnormal preimplantation embryos detected by fluorescence in situhybridisation. Hum Genet 94:609–615 (1994).
8.
Coonen E, Derhaag JG, Dumoulin JC, Van Wissen LC, Bras M, et al: Anaphase lagging mainly explains chromosomal mosaicism in human preimplantation embryos. Hum Reprod 19:316–324 (2004).
9.
Conlin LK, Thiel BD, Bonnemann CG, Medne L, Ernst LM, et al: Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Molec Genet 19:1263–1275 (2010).
10.
Daphnis DD, Delhanty JD, Jerkovik S, Geyer J, Craft I, Harper JC: Detailed FISH analysis of day 5 human embryos reveals the mechanisms leading to mosaic aneuploidy. Hum Reprod 20:129–137 (2004).
11.
Delhanty JD, Handyside AH: The origin of genetic defects in the human and their detection in the preimplantation embryo. Hum Reprod Update 1:201–215 (1995).
12.
Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, et al: Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation (FISH). Hum Molec Genet 2:1183–1185 (1993).
13.
Delhanty JD, Harper JC, Ao A, Handyside AH, Winston RM: Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet 99:755–760 (1997).
14.
Dupont C, Bavister BD, Armant DR, Brenner CA: Rhesus macaque embryos derived from MI oocytes after retrieval display high rates of chromosomal anomalies. Hum Reprod 24:929–935 (2009).
15.
Dupont C, Segars J, De Cherney A, Bavister BD, Armant DR, Brenner CA: Incidence of chromosomal mosaicism in morphologically normal nonhuman primate preimplantation embryos. Fertil Steril 93:2545–2550 (2010).
16.
Eakin GS, Hadjantonakis AK, Papaioannou VE, Behringer RR: Developmental potential and behavior of tetraploid cells in the mouse embryo. Dev Biol 288:150–159 (2005).
17.
Fragouli E, Bianchi V, Patrizio P, Obradors A, Huang Z, et al: Transcriptomic profiling of human oocytes: association of meiotic aneuploidy and altered oocyte gene expression. Mol Hum Reprod 16:570–582 (2010).
18.
Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D: Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437:1043–7 (2005).
19.
Ganem NJ, Storchova Z, Pellman D: Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17:157–162 (2007).
20.
Griffin DK, Handyside AH, Harper JC, Winston RM, Delhanty JD:Clinical experience with preimplantation diagnosis of sex by dual fluorescent in situhybridization. J Assist Reprod Genet 11:132–143 (1994).
21.
Harper JC, Coonen E, Handyside AH, Winston RM, Hopman AH, Delhanty JD: Mosaicism of autosomes and sex chromosomes in morphologically normal, monospermic preimplantation human embryos. Prenat Diagn 15:41–49 (1995).
22.
Harrison RH, Kuo HC, Scriven PN, Handyside AH, Ogilvie CM: Lack of cell cycle checkpoints in human cleavage stage embryos revealed by a clonal pattern of chromosomal mosaicism analysed by sequential multicolour FISH. Zygote 8:217–224 (2000).
23.
Hartwell LH, Weinert EA: Checkpoint controls that ensure the order of cell cycle events. Science 246:629–634 (1989).
24.
Hassold TJ, Jacobs PA: Trisomy in man. Annu Rev Genet 18:69–97 (1984).
25.
Jamieson ME, Coutts JR, Conner JM: The chromosome constitution of human preimplantation embryos fertilised in vitro. Hum Reprod 9:709–715 (1994).
26.
Katz-Jaffe M, Trounsen AO, Cram DS: Mitotic errors in chromosome 21 of human preimplantation embryos are associated with non-viability. Mol Hum Reprod 10:143–147 (2004).
27.
Lightfoot DA, Kouznetsova A, Mahdy E, Wilbertz J, Hoog C: The fate of mosaic aneuploid embryos during mouse development. Dev Biol 289:384–394 (2006).
28.
Magli MC, Gianaroli L, Ferraretti AP, Gordts S, Fredericks V, Crippa A: Paternal contribution to aneuploidy in preimplantation embryos. Reprod Biomed Online 18:536–542 (2009).
29.
Mantzouratou A, Mania A, Fragouli E, Xanthopoulou L, Tashkandi S, et al: Variable aneuploidy mechanisms in embryos from couples with poor reproductive histories undergoing preimplantation genetic screening. Hum Reprod 22:1844–1853 (2007).
30.
Margolis RL, Lohez OD, Andreassen PR: G1 tetraploidy checkpoint and the suppression of tumorigenesis. J Cell Biochem 88:673–683 (2003).
31.
Munné S, Grifo J, Cohen J: Chromosome abnormalities in human arrested preimplantation embryos fertilized in vitro: a multiprobe FISH study. Am J Hum Genet 55:150–159 (1994).
32.
Munné S, Alikani M, Tomkin G, Grifo J, Cohen J: Embryo morphology, developmental rates and maternal age are correlated with chromosome abnormalities. Fertil Steril 64:382–391 (1995).
33.
Munné S, Sandalinas M, Escudero T, Marquez C, Cohen J: Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect. Reprod Biomed Online 4:223–232 (2002).
34.
Munné S, Bahçe M, Sandalinas M, Escudero T, Márquez C, et al: Differences in chromosome susceptibility to aneuploidy and survival to first trimester. Reprod Biomed Online 8:81–90 (2004).
35.
Murray AW: Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599–604 (1992).
36.
Northrop LE, Treff NR, Levy B, Scott RT: SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod 16:590–600 (2010).
37.
Rodríguez-Santiago B, Malats N, Rothman N, Armengol L, Garcia-Closas M, et al: Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome. Am J Hum Genet 87:129–138 (2010).
38.
Rubio C, Simon C, Vidal F, Rodrigo L, Pehlivan T, et al: Chromosomal abnormalities and embryo development in recurrent miscarriage couples. Hum Reprod 18:182–188 (2003).
39.
Shi Q, King RW: Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437:1038–1042 (2005).
40.
Steuerwald NM, Bermudez MG, Wells D, Munné S, Cohen J: Maternal age-related differential global expression profiles observed in human oocytes. Reprod Biomed Online 14:700–708 (2007).
41.
Verpoest W, Fauser BC, Papanikolaou E, Staessen C, Van Landuyt L, et al: Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. Hum Reprod 23:2369–2371 (2008).
42.
Voullaire L, Slater H, Williamson R, Wilton L: Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridisation. Hum Genet 106:210–217 (2000).
43.
Voullaire L, Wilton L, McBain J, Callaghan T, Williamson R: Chromosome abnormalities identified by comparative genomic hybridization in embryos from women with repeated implantation failure. Mol Hum Reprod 8:1035–1041 (2002).
44.
Voullaire L, Collins V, Callaghan T, McBain J, Williamson R, Wilton L: High incidence of complex chromosome abnormality in cleavage embryos from patients with repeated implantation failure. Fertil Steril 87:1053–1058 (2007).
45.
Wells D, Delhanty JD: Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridisation. Molec Hum Reprod 6:1055–1062 (2000).
46.
Wells D, Bermudez MG, Steuerwald N, Thornhill AR, Malter H, et al: Expression of genes regulating chromosome segregation, the cell cycle and apoptosis during human preimplantation development. Hum Reprod 20:1339-1348 (2005)
47.
Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, et al: Incidence of early loss of pregnancy. New Engl J Med 319:189–194 (1988).
48.
Zeng P, Dean J: Role of Filia, a maternal effect gene, in maintaining euploidy during cleavage-stage mouse embryogenesis. Proc Natl Acad Sci 106:7473–7478 (2009).
49.
Zenzes MT, Caspar RF: Cytogenetics of human oocytes, zygotes, and embryos after in vitro fertilization. Hum Genet 88:367–375 (1992).
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
